Cotinine Plus Krill Oil Decreased Depressive Behavior, and Increased Astrocytes Survival in the Hippocampus of Mice Subjected to Restraint Stress by Mendoza, Cristhian et al.
ORIGINAL RESEARCH
published: 17 December 2018
doi: 10.3389/fnins.2018.00952
Frontiers in Neuroscience | www.frontiersin.org 1 December 2018 | Volume 12 | Article 952
Edited by:
Rubem C. A. Guedes,
Federal University of Pernambuco,
Brazil
Reviewed by:
Roberta Monterazzo Cysneiros,
Mackenzie Presbyterian University,
Brazil
Nafisa M. Jadavji,
Carleton University, Canada
*Correspondence:
Valentina Echeverria
echeverria.valentina@gmail.com
Specialty section:
This article was submitted to
Neuroenergetics, Nutrition and Brain
Health,
a section of the journal
Frontiers in Neuroscience
Received: 24 July 2018
Accepted: 30 November 2018
Published: 17 December 2018
Citation:
Mendoza C, Perez-Urrutia N,
Alvarez-Ricartes N, Barreto GE,
Pérez-Ordás R, Iarkov A and
Echeverria V (2018) Cotinine Plus Krill
Oil Decreased Depressive Behavior,
and Increased Astrocytes Survival in
the Hippocampus of Mice Subjected
to Restraint Stress.
Front. Neurosci. 12:952.
doi: 10.3389/fnins.2018.00952
Cotinine Plus Krill Oil Decreased
Depressive Behavior, and Increased
Astrocytes Survival in the
Hippocampus of Mice Subjected to
Restraint Stress
Cristhian Mendoza 1, Nelson Perez-Urrutia 1, Nathalie Alvarez-Ricartes 1,
George E. Barreto 2,3, Raquel Pérez-Ordás 4, Alex Iarkov 1 and Valentina Echeverria 1,5*
1Universidad San Sebastián, Fac. Cs de la Salud, Concepción, Chile, 2Departamento de Nutrición y Bioquímica, Facultad de
Ciencias, Pontificia Universidad Javeriana, Bogotá, Colombia, 3 Instituto de Ciencias Biomédicas, Universidad Autónoma de
Chile, Santiago, Chile, 4 Facultad de Ciencias de la Actividad física y el deporte, Universidad Pablo de Olavide, Sevilla, Spain,
5 Research & Development Service, Bay Pines VA Healthcare System, Bay Pines, FL, United States
Restraint stress (RS) is a condition affecting millions of people worldwide. The
investigation of new therapies to alleviate the consequences of prolonged RS is much
needed. Cotinine, a nicotine-derivative, has shown to prevent the decrease in cerebral
synaptic density, working memory deficits, anxiety, and depressive-like behavior after
prolonged restraint stress (RS) in mice. Furthermore, post-treatment with cotinine
reduced the adverse effects of chronic RS on astrocyte survival and architecture. On
the other hand, the nutritional supplement krill oil (KO), has shown to be beneficial in
decreasing depressive-like behavior and oxidative stress. In this study, in the search for
effective preventative treatments to be used in people subjected to reduced mobility,
the effect of co-treatment with cotinine plus KO in mice subjected to prolonged RS was
investigated. The results show that cotinine plus KO prevented the loss of astrocytes,
the appearance of depressive-like behavior and cognitive impairment induced by RS.
The use of the combination of cotinine plus KO was more effective than cotinine alone in
preventing the depressive-like behavior in the restrained mice. The potential use of this
combination to alleviate the psychological effects of reduced mobility is discussed.
Keywords: depression, cotinine, anxiety, restraint stress, krill oil, astrocytes
INTRODUCTION
Stress is generated when an individual is unable to cope with overwhelming physical or
psychological demands. Although, the hormonal and behavioral changes that occur in response
to threatening stimuli is crucial for survival and can be beneficial in recruiting adaptive responses
to cope with a stressful situation, however, prolonged stress can result in maladaptive changes that
may lead to mental illness, cognitive and motor deficits (Yehuda et al., 1998; Hammen, 2003; Luine
et al., 2007).
In the clinical realm, the emotional and physical alterations induced by RS further diminish
the quality of life of people with restricted mobility as stress/induced Neuroinflammation induce
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depression (Iwata et al., 2013; Muscatelli et al., 2017). A meta-
analysis including 354 studies, 18,374 individuals revealed that
more than 70% of depressed individuals showed signs of stress
such as elevated cortisol levels in plasma(Stetler and Miller,
2011).
Stress response when engaged for extended durations or
activated by a traumatic event; it is linked to the dysregulation
of the Hypothalamus-pituitary-adrenal (HPA) axis (Bauer
et al., 2001). This dysregulation results in altered levels of
glucocorticoid hormones and neurotransmitters in the brain
and may lead to psychological depression (Hayase, 2011). For
example, since the HPA axis has bidirectional relationships
with the serotoninergic system its dysregulation can result
in decreased levels of serotonin leading to depression and
irritability. Also, neurons from the amygdala (AMY), which
are responsive to the corticotropin-releasing hormone (CRH),
project to the raphe nuclei, the main serotonin source to the
forebrain. In addition, dysregulation of the HPA axis correlates
with morphological alterations of the brain such as the reduction
of hippocampal volume observed in individuals with major
depressive disorder (MDD) and posttraumatic stress disorder
(PTSD) (Sheline, 2000; Bonne et al., 2001; Czeh et al., 2001;
Schmitz et al., 2002; Villarreal et al., 2002; Drevets et al., 2008;
Felmingham et al., 2009; Apfel et al., 2011; Filipovic et al., 2011;
Gonul et al., 2011; Teicher et al., 2012; Admon et al., 2013;
Ahmed-Leitao et al., 2016).
Chronic stress has many other harmful effects on
the brain including neuroinflammation, oxidative stress,
microgliosis, reduced neurogenesis, and diminished numbers
and architectural complexity of neurons. Chronic stress also
evokes synaptic alterations including spine number and shape
(Kassem et al., 2013; Bennett and Lagopoulos, 2014; Scharfman
and MacLusky, 2014). In rodents, restraint stress (RS) affects
spatial memory (Bowman et al., 2002; Kleen et al., 2006)
and long-term potentiation, a cellular model of learning and
memory processes, in the hippocampus (Pavlides et al., 2002).
Such effects have been associated with the retraction of apical
dendrites, as well as the loss of synapses in the CA1, CA3, and
dentate gyrus (DG) sub-regions of the hippocampus (McEwen
et al., 1997; Magarinos et al., 2011). These cellular changes and
brain connectivity, contribute to the development of PTSD in
people subjected to trauma and suffering with reduced mobility.
As a result, several neurological symptoms appear such as
working memory loss, impulsivity, aggressive behavior, and
depression in traumatized individuals who developed PTSD
(Tafet and Bernardini, 2003; Reagan et al., 2008; Conrad and
Bimonte-Nelson, 2010; Luine, 2016; Moreira et al., 2016).
Abbreviations: AMPA, α -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid;
ANOVA, Analysis of variance; CRH, corticotrophin releasing hormone; FS, Forced
swimming; GFAP, Glial fibrillary acidic protein; HPA, Hypothalamus-pituitary-
adrenal; IR, Immunoreactivity; KO, Krill oil; MD, Major depression; MAOIs,
Monoamine oxidase inhibitors; MGV, Mean gray values; NOR, Novel object
recognition; OF, Open field; PBS, Phosphate buffered saline; PFC, Prefrontal
cortex; PTSD, Posttraumatic stress disorder; ROI, Region of interest; SSRIs,
Region serotonin-reuptake inhibitors; SNRIs, Serotonin-norepinephrine reuptake
inhibitors; TBS, Tris-buffered saline; TBST, TBS with 0.1% Tween 20.
Numerous studies have emphasized the role of astrocytes
in mediating brain homeostasis by supporting the blood-brain
barrier function, sustaining neuronal energymetabolism (Stobart
and Anderson, 2013), and neurotransmission (Schousboe et al.,
1992). Furthermore, astrocytes modulate synaptic plasticity
processes including synaptogenesis, neurogenesis, and learning
and memory (Honsek et al., 2012; Bernardinelli et al.,
2014; Haydon and Nedergaard, 2014). For these reasons,
astrocytes are considered useful therapeutic targets for several
neurological disorders (Garzon et al., 2016; Gonzalez-Giraldo
et al., 2017).
Astrocytes have been classified according to their cellular
morphologies (cell body size, and number, length, thickness,
direction, and length of processes) and location, in two main
subtypes, protoplasmic or fibrous (Sofroniew and Vinters, 2010).
Protoplasmic astrocytes are found in the gray matter and present
numerous stem branches that originate from several branching
processes in a regular sphere-like distribution. Fibrous astrocytes
have elongated processes and are present in the white matter
(Sofroniew and Vinters, 2010). It has been proposed that the
morphology of astrocytes can be a good indicator of their
functions (de Filippis, 2011). Recently, Choi et al. studied the
molecular and morphological changes of astrocytes induced by
fear conditioning; the results showed a significant decrease of
the immunoreactivity (IR) for the glial fibrillary acidic protein
(GFAP) in the hippocampus of fear conditioned rodents (Saur
et al., 2016). Our team found a similar reduction in the
number of GFAP+ astrocytes in the CA1, CA3, and DG of
the hippocampus after prolonged restraint stress (RS) in mice
(Perez-Urrutia et al., 2017). Previous studies indicated that in the
hippocampal formation posttreatment with cotinine normalized
the number of GFAP+ astrocytes astrocyte and GFAP IR, in
all hippocampal regions being the effect especially significant in
the DG.
In this study, our goal was to assess the effect of co-
treatment with KO plus cotinine on GFAP+ IR in the DG,
and depressive-like behavior and working memory in a mouse
model of prolonged RS. The results highlight the advantage of
using cotinine plus a natural antioxidant nutrient to diminish
stress-derived depressive behavior, cognitive impairment,
and astrocytes abnormalities in the hippocampus after
prolonged RS.
MATERIALS AND METHODS
Animals
Two-month-old male C57BL/6J mice (obtained from the
University of Chile), weighing 25-30 g, were maintained on a 12-
h (h) light/dark cycle (light on at 07:00 h) with ad libitum access
to food and water andmaintained at a controlled temperature (25
± 1◦C). Upon arrival, mice were group housed and acclimated
for 7 days before behavioral testing. Experiments were completed
during the light period of the circadian cycle. Animal handling
and care were performed in compliance with the Guide for the
care and use of laboratory animals adopted by the National
Institute of Health (USA), according to a protocol approved
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by the ethical committee of the Universidad San Sebastian,
Chile.
Drug Preparation
Cotinine ((5S)-1-methyl-5-(3-pyridyl) pyrrolidine-2-one)
(Sigma-Aldrich Corporation, St. Louis, MO, USA) was prepared
by dissolving the powdered compound in sterile phosphate
buffered saline (PBS). KO capsules (300mg) were purchased
from Walgreens (Superba, USA). Soft gels contain 300mg KO
(90mg omega-3 fatty acids, 50mg eicosapentaenoic acid, 24mg
docosahexaenoic acid, 130mg phospholipids). Manufacturers
provided no information about the Astaxanthin content in the
soft gels.
Experimental Groups and Drug Treatments
Initially, the mice were acclimated for 1 week and subjected to
handling to reduce stress. Then, mice were randomly divided into
five groups (n = 8 mice/condition) and treated via gavage with
0.05ml of vehicle (PBS, pH 7.4), Cotinine (Cot), KO or Cot plus
KO dissolved in 0.05ml of vehicle as detailed: (1) control non-
restrained mice treated with vehicle; (2) restrained mice treated
with vehicle; (3) restrained cotinine-treated mice (5 mg/kg in
vehicle); (4) restrained KO-treated mice (143 mg/kg in vehicle);
(5) restrained mice treated with cotinine (5 mg/kg) plus KO (143
mg/kg, in vehicle). Mice were treated via at the same time of
the day, 30min (min) before restraint and continuously until
euthanasia. After 21 days (d) into treatments, mice were tested
for behavior in the order from less stressful test to more stressful
as indicated in Figure 1, with 24 of resting between tests to permit
adequate resting of mice and to prevent interference between
test. After the end of experiments, mice were euthanized using
cervical dislocation by well-trained personnel.
Behavioral Procedures
Restraint Stress
RS is a reliable method to model chronic stress that mimics
the effects of restraint stress on brain functions and behavior in
rodents (Pare and Glavin, 1986; Jaggi et al., 2011). Mice were
gently introduced into 50-ml conical transparent plastic tubes
(Corning Inc.) containing non-protruding perforations in both
ends and in the walls to permit ventilation. Mice were kept inside
these tubes, allowing slight movements, for 6 h a day for 21 d at
room temperature (RT). After the daily restraint time, mice were
returned to their home cages and permitted to move freely for the
rest of the day. Following the 3 weeks of RS, mice were tested for
locomotor activity and depressive-like behavior.
Open Field Test (OF)
The open field (OF) test (Belzung and Griebel, 2001) was
conducted as previously described with minor modifications
(Norcross et al., 2008) to identify changes in locomotor activity
in response to stress and drug treatments. Mice were individually
placed in a corner and permitted to freely explore an open square
arena (40 × 40 × 35 cm) for 10min (Figure 2A). Total distance
traveled, speed and time spent in the center zone were measured
under moderate lighting using the video tracking software (ANY-
Maze, Stoelting Co.).
Forced Swim Test
The forced swim (FS) is a broadly used task to assess depressive-
like behavior in rodents (Dalla et al., 2010). The FS is performed
introducing each mouse in the surface of a transparent and
inescapable cylinder two-thirds filled with water at 26 ± 1◦C
(Figure 3A). Mice engage in periods of intense movement
followed for increasing periods of immobility. The immobility
time is considered an expression of depressive-like behavior.
Immobility time is defined as no longer exhibiting any escape
behavior, motionless or moving only to keep floating. Immobility
time during a 5-min trial was recorded and quantified by two
investigators blind to the treatment groups.
Novel Object Recognition (NOR)
This task evaluates recognition memory, and it is based on the
natural preference of rodents for novel objects when exposed to
new and previously encountered objects (de Bruin and Pouzet,
2006). During the task, favored exploration of the novel object
provides a measure of recognition memory. After a habituation
step in a square arena (40 × 40 × 35 cm), each mouse was
placed in the same arena but containing two identical transparent
objects located equidistant to each other (familiarization phase)
and led to explore the objects for 5min (Figure 4A). Then, mice
were returned to their cages and permitted to rest for 30min.
After resting, mice were placed back in the arena containing one
of the familiar objects and a new object (Figure 4B). The time
exploring the two objects was recorded for 5min. Exploratory
behavior was recorded and the time of exploration of each object
was normalized for animal activity by calculating the exploration
index (EI) that corresponds to the time spent by the mouse
exploring one of the equal objects or the new object/ total time
spent exploring both objects × 100%. The behavioral recording
and analysis were performed using the (ANY-Maze, Stoelting
Co.).
Sucrose Preference Test
The sucrose preference test was used to assess anhedonia, an
indicator of depressive-like behavior. The sucrose preference test
was performed as previously described (Serchov et al., 2016)
with some modifications. The mice were habituated given two
identical bottles with tap water in their cage. Then, mice were
given free access to both, one with 2% sucrose solution and
another with tap water for 3 days. The position of bottles was
switched daily to avoid place preference in drinking behavior.
Bottle weights were taken every day to determine solution intake.
The preference for sucrose was calculated as a percentage of the
volume of sucrose intake over the total volume of fluid intake and
averaged over the 3 days of the test.
Morphological Analyses of Astrocytes in
the Dentate Gyrus
Brain Tissue Preparation
For the protein analyses, mice were euthanized, and brains
removed. The left hemisphere of brains was dissected out to
collect the regions of interest and quickly frozen for later
biochemical analyses. For the immunohistochemistry (IHC) and
fluorescent IHC (F-IHC) analysis, the right hemisphere of each
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FIGURE 1 | Experimental design. Mice were subjected to restraint stress 6 h/day for 21 days and co-treated with PBS, krill oil (KO), Cotinine (Cot) or Cot plus KO.
After restraint and under continuing treatments, mice were tested for locomotor function, recognition memory using the novel object recognition test (NOR) and
depressive-like behavior using the forced swim (FS) test and the sugar preference test (SPT).
FIGURE 2 | Co-treatment with cotinine and krill oil does not affect locomotor activity in mice. After prolonged restraint stress (RS) and co-treatment with vehicle (PBS),
cotinine (Cot, 5 mg/kg), krill oil (KO, 143 mg/kg) or (Cot plus KO), mice were tested for locomotor activity in the open field test for 25min. The results show the effect of
RS and treatments on. Time in the center zone (A) and total distance travelled (B).
mouse brain was placed in 4% paraformaldehyde in PBS pH 7.4
at 4◦C for 24 h. The tissues were embedded in 2% agarose molds
for vibratome sectioning. The region of interest was located using
the Paxinos Atlas as a reference (Franklin and Paxinos, 1997), and
serial sections of 20µm (n ≥ 2/mouse) were collected using the
Vibratome Leica VT1000S and placed on positively charged slides
(Biocare Medical, Concord, CA).
Immunofluorescence and Confocal Microscopy
For the F-IHC, samples were washed three times for 7min with
Tris-buffered saline (TBS), pH 7.8. The primary antibody anti-
GFAP (1:50, BioSB) was diluted in diluent buffer, containing
TBS supplemented with 1% bovine serum albumin (BSA) and
0.2% Triton X-100 and incubated with the tissue sections
overnight (ON) at 4◦C. After three washes with TBS for
10min, sections were incubated with the secondary antibody,
Cy2-conjugated rabbit anti-mouse IgG (1:200, Jackson Immuno
Research, Pennsylvania, USA) diluted in TBS containing 1% BSA
for 2 h at RT. The samples were counterstained with Hoechst
(1:1,000) and mounted with fluorescence mounting medium
(Prolong, Invitrogen). Confocal z-stacks were acquired using an
LSM 780 confocal microscope (Zeiss, Oberkochen, Germany), z-
stacks were normalized to maintain a consistent signal intensity
through the depth of the sample, confocal z-stack image series
were superposed in maximum intensity projections by ImageJ
(National Institute of Health, Bethesda, MA, USA) for the
measurements.
Morphometric Analysis and Cell Counting
In each image, regions of interest (ROI) were defined on the
dentate gyrus using free-hand drawing. For each ROI, the mean
gray values (MGV), representing the area immunoreactive for
GFAP, were measured. To measure GFAP immunostaining in
the DG, maximum fluorescence intensity projections of confocal
z-stacks acquired from sagittal brain sections were converted
into 8-bit greyscale images with 256 scales (pixel intensity 0
corresponding to no signal and 255 to maximal signal) by Image
J software. To calculate the area fraction of GFAP+ IR, binary
images the immunoreactive area of the thresholded images was
divided by the total of the ROI. For the GFAP+ cell counting, cell
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FIGURE 3 | Co-treatment with cotinine and krill oil does not affect locomotor activity in mice. After prolonged restraint stress (RS) for 10min and co-treatment with
vehicle (PBS), cotinine (Cot, 5 mg/kg), krill oil (KO, 143 mg/kg) or (Cot plus KO). The results show that RS did not significantly affect locomotor activity in the stressed
mice. (A) Total distance traveled. (B) Mean speed (meters/seconds) (C) Time in the center zone. *P < 0.05, **P < 0.01.
FIGURE 4 | Co-treatment with cotinine plus krill oil prevented the restraint stress-induced depressive-like behavior in mice. After three-week restraint and
co-treatment with vehicle (PBS), cotinine (Cot, 5 mg/kg) or krill oil (KO, 143 mg/kg), mice were tested for depressive-like behavior in the forced swim tests (5min).
(A) or the sucrose preference tests (B). *P < 0.05, **P < 0.01, ***P < 0.001.
to be counted must have at least half of the cell nucleus visible on
the edge of the ROI and cells to be included in the analysis must
be not adherent to blood vessels.
Statistical Analysis
To analyze group and treatment effects differences in the means
between groups one-way analysis of variance (ANOVA), and
post hoc Dunnet’s test was performed using the GraphPad
Prism software to assess difference significance between groups.
Differences were considered significant with P < 0.05.
RESULTS
Effect of Krill oil and Cotinine on
Locomotor Activity
To determine the changes in locomotor activity induced by co-
treatments during RS, mice were tested using the OF test for
25min. The results show that stressed mice showed higher time
spent in the center zone than non-stressed controls in the first
10min of the tests, but the differences diminished after this
time between groups. The time spent in the center zone by the
different groups was significantly different in the first 5min of
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the OF test [F (4, 63) = 6.42, P < 0.0003; Figure 2A]. At the
contrary, the distance traveled show marked differences between
non-stressed mice and all groups of stressed mice, independent
of treatments (Figure 2B). Considering these results we proceed
to analyze the changes in locomotor activity in the OF during
the first 10min of testing. One-way ANOVA analysis revealed
significant differences in the distance traveled in the first 10min
[F(7, 67) = 16, P < 0.0001; Figure 3A] and speed [F(7, 76) = 8.91,
P < 0.0001; Figure 3B]. There were no statistically significant
differences in distance traveled or speed between non-stressed
mice treated with vehicle, cotinine or KO. However, they showed
significantly lower distances than non-stressed mice treated with
KO plus cot (P <0.05), and restrained mice treated with vehicle,
cotinine, KO or KO plus Cotinine (P < 0.0001).
The increase in distance traveled was accompanied by a
significant increase in speed in the mice subjected to RS when
compared to non-stressed vehicle-treated mice (& RS, P < 0.05;
& RS plus Cot P < 0.05; & RS, KO, P < 0.01; & RS, KO plus
Cot, P < 0.05; Figure 3B). Also, the time spent in the center
zone during the first 10min of testing was analyzed, when anxiety
behavior was more evident. The results showed that in the first
10min there was a non-significant increase in time spent in the
center zone between control non-stressed mice and the mice
subjected to RS [F(7, 67)= 2.11, P< 0.053] (Figure 3C). However,
these differences were significant between treatment groups after
5min of testing [F(4, 67) = 9.17, P < 0.0001; (Figure 2A) with
significant differences between non-stressed mice and stressed-
mice independent of treatments (& RS, P< 0.0001; & RS plus Cot
P < 0.001; & RS, KO, P < 0.001; & RS, KO plus Cot, P < 0.0001).
Effect of Krill Oil and Cotinine on
Depressive-like Behavior
To investigate the potential anti-depressant effects of cotinine,
KO and KO plus cotinine when administered during stress, at
the last day of RS mice were tested for depressive-like behavior
using the forced swim test and sucrose preference test (Figure 4).
A two-way ANOVA showed a significant impact of prolonged RS
on the level of depressive-like behavior, expressed as a general
increase in the immobility time during the FS test by the
restrained mice when compared to control mice [F(1,38) = 15.35,
P = 0.0004]. Also, this analysis revealed a significant effect of
treatments on depressive-like behavior [F(3,38)= 5.23, P= 0.004].
Multiple comparison tests showed that mice subjected to RS
and co-treated with Cot (P < 0.05), KO (P < 0.05) or KO
plus cotinine (P < 0.01) showed lower levels of immobility than
vehicle-treated restrained mice (Figure 4A).
To corroborate the antidepressant effect of treatments, a
sucrose preference tests were performed. Also, the sucrose
preference test revealed significant differences between
treatments. One-way ANOVA revealed a significant effect of
chronic stress in sucrose preference [F(4, 28) = 8.65, P = 0.0001].
Multiple comparison tests showed significant decrease in sucrose
preference in the vehicle-treated restrained mice when compared
to vehicle-treated non-stressed mice. However, treatments
showed antidepressant effects and the stressed mice treated
with cotinine (P < 0.001), KO (P < 0.001) or cotinine plus KO
(P < 0.05) showed significantly lower levels of anhedonia and
higher sucrose consumption than the restrained mice treated
with vehicle (Figure 4B).
Effect of Krill Oil and Cotinine on
Recognition Memory
To assess whether co-treatment with cotinine during RS
influenced recognition memory, mice were tested in the
novel object recognition NOR test. Non-significant differences
were found between non-stressed and restrained mice in the
familiarization step of the task, and all mice explored each
of the two objects almost 50% of the time, no showing a
preference for any of them (Figure 5A). However, when mice
were exposed to one old object and a new object in the arena, one-
way ANOVA analysis revealed significant differences between
groups on recognition memory [F(4,48) = 4.29, P = 0.0049].
Multiple comparison tests showed a significant difference in
the time spent with the new object between the vehicle-treated
non-restrained mice and the vehicle-treated restrained mice
(P < 0.05). However, restrained mice treated with cotinine
plus KO showed no differences in recognition working memory
reflected as a similar level of preference for the new object than
vehicle-treated non-restrained mice (P > 0.05) (Figure 5B).
Analysis of Changes in Morphology and
Cell Viability of GFAP+ Astrocytes
Cell Counting
To assess changes induced by RS and treatments on astrocyte
architecture and numbers. The number of GFAP+ cells, GFAP IR
and area fraction were investigated in the DG, one of the region
more affected in those parameters by RS (Perez-Urrutia et al.,
2017).
Multiple comparison tests revealed no significant effects of
treatments in GFAP IR in the non-stressed mice, but significant
differences in the restrained mice. One-way ANOVA analysis of
GFAP+ cells in the DG showed a significant effect of treatments
on the number of GFAP+ cells in the DG [F(7, 46) = 4.88,
P = 0.0004]. GFAP+ cell densities in the DG were significantly
reduced in the vehicle-treated restrained mice when compared
to vehicle-treated non-stressed mice (P < 0.001). Treatment with
KO alone did not induced changes in the number of GFAP+ cell
in the KO-treated restrained mice, when compared to vehicle-
treated restrained mice. However, a substantial increase of
GFAP+ IR cells was observed in the cotinine-treated restrained
mice or KO plus cotinine, when compared to vehicle-treated
restrained mice (P < 0.05) (Figures 6A,B).
Mean Gray Value
One-way ANOVA analysis of mean GFAP IR in the GFAP+ cells
in the DG showed a significant effect of treatments on GFAP
IR intensity in the DG [F(7, 33) = 5.10, P = 0.0005]. Multiple
comparison tests revealed no significant effects of treatments
on the mean GFAP IR in the non-stressed mice. However,
a significant decrease in the mean IR intensity was found in
the vehicle-treated restrained mice group when compared to
vehicle-treated non-restrained mice (P < 0,05). Nonsignificant
changes in GFAP IR were found in the KO-treated restrained
mice when compared to the vehicle-treated restrained mice
(P > 0.05). On the other hand, a significant increase of IR
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FIGURE 5 | Co-treatment with cotinine decreased the restraint stress-induced deficit in recognition memory. After restraint and co-treatment with vehicle (PBS),
cotinine (Cot, 5 mg/kg) krill oil (KO, 143 mg/kg) or Cot plus KO, mice were tested for locomotor activity in the open field test and next day mice were tested for
recognition memory in the novel object recognition test (NOR). (A) Familiarization: mice were individually exposed to two identical objects. (B), Novel object recognition
step: after 30min of rest, mice were exposed to one of the old objects and a new object. Chronic restraint stress impaired novel object recognition. Co-treatment with
KO plus Cot preserved recognition memory abilities in the stressed mice to levels non-significantly different from control non-stressed mice. **P < 0.01.
FIGURE 6 | Analysis of the effect of cotinine plus krill oil on astrocytes in the dentate gyrus of the hippocampus. A figure representing the changes in cell GFAP+ cells
numbers and morphology in the dentate gyrus region of the hippocampus in male mice subjected or not to restraint stress (R. Stress) (A). Graph depicting the
changes in the number of GFAP+ IR cells (B); main gray values (MGV) (C); area of GFAP IR in the DG of vehicle-treated non-retrained mice or restrained (RS) mice,
cotinine (Cot, 5 mg/kg) or Cot plus KO (143 mg/kg) (Cot + KO) (D). *P < 0.05, **P < 0.01, ***P < 0.001.
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intensity was found in the cotinine-treated restrained mice when
were compared to vehicle-treated restrained mice (P < 0.01).
Also, there was a significant increase in GFAP IR in the KO
plus cotinine-treated restrained mice when compared to vehicle-
treated restrained mice (P < 0.01; Figure 6C).
Area Fraction
The analysis of the percent area fraction occupied by GFAP+
cells revealed significant effects of treatments in the DG
[F(7, 34) = 17.28, P < 0.0001]. Multiple comparison analysis
showed that vehicle-treated restrained mice show a significant
decrease of the GFAP+ IR area in comparison to non-stressed
vehicle-treated mice (P < 0,001). Nevertheless, a significant
increase in the GFAP+ IR fraction area was found in the
cotinine and KO plus cotinine-treated restrained mice when
compared to vehicle-treated restrained mice (P < 0.001) in the
DG (Figure 6D).
DISCUSSION
Chronic immobilization or reduced mobility stress can result
from obesity, paralysis induced by vascular events such as stroke,
spinal cord injury, advanced age, and many neurodegenerative
conditions such as arthrosis, and ataxia. These events result in
depression and cognitive impairment in the affected individuals.
RS is a broadly used model of stress-induced depressive-like
behavior (Buynitsky and Mostofsky, 2009). Prolonged RS results
in morphological changes in the brain such as retraction of
processes in hippocampal neurons and astrocytes (Magarinos
et al., 1997; McEwen et al., 1997), neuroinflammation (Bauer
et al., 2001; de Andrade et al., 2012; Tymen et al., 2013), and
cognitive deficits (Thorsell et al., 2000; Abidin et al., 2004; Conrad
et al., 2004; Cherian et al., 2009; Mika et al., 2012) and depressive-
like behavior in rodents (Buynitsky and Mostofsky, 2009; Chiba
et al., 2012). It has been shown that cotinine administered
before and after RS, reduces the depressive-like behavior, synaptic
deficits, astrocyte alterations, and cognitive impairment in mice
(Grizzell et al., 2014; Grizzell and Echeverria, 2015; Perez-Urrutia
et al., 2017). In this study, it was investigated the effect of co-
treatment with cotinine combined with KO, during chronic RS,
on the development of depressive-like behavior and cognitive
impairment induced by chronic stress in mice. RS provoked
a decrease in recognition memory abilities and depressive-like
behavior in the mice, however, cotinine plus KO prevented these
behavioral changes. These results showed a synergistic beneficial
effect of both cotinine and KO in preserving mood stability and
cognitive abilities under conditions of chronic RS.
At the neurochemical level, chronic stress induces a deficit
in glutamatergic neurotransmission by mechanisms involving
a decrease of NMDA (N-Methyl-D-aspartate) and AMPA
(α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)
receptors in the postsynaptic site in the prefrontal cortex and
the hippocampus, two brain regions that are fundamental
for mediating declarative and working memory abilities. This
reduction in the number of synaptic glutamate receptors induces
a decrease in the activity of brain networks controlling stress
behavior including the prefrontal cortex-amygdala-hippocampus
pathways. Some evidence suggests that loss of glutamate
FIGURE 7 | Diagram representing the effect of cotinine and krill oil preventing
the effects of chronic stress on astrocyte and neuronal function and behavior.
Cotinine plus KO may counteract the neuroinflammatory and oxidative
processes triggered by chronic stress in the brain. This effect may prevent the
reduction in astrocyte affecting their role supporting the neuronal plasticity
processes that are required for working memory and mood stability affected
by chronic stress.
receptors in neurons of the prefrontal cortex after repeated stress
in rats, it is due to increased ubiquitin–proteasome-dependent
degradation of these receptors (Joels et al., 2004; Yuen et al.,
2012). Furthermore, previous studies using rodent models of
chronic stress found a reduced proliferation of glial progenitor
cells, and a decrease of GFAP+ cells in several brain regions,
including the hippocampus and prefrontal cortex in rats. In
rats, glucocorticoids can diminish the expression of GFAP in the
PFC, resulting in >20% reduction in GFAP expression that was
accompanied by a decrease of the GFAP mRNA levels (Zschocke
et al., 2005). Also, chronic RS inhibits the glutamate uptake by
astrocytes enhancing excitotoxicity and long-term depression
(Yang et al., 2005). Furthermore, some evidence shows that rats
exposed to early-life stress have a decrease in astrocytes levels in
the frontal cortex in adulthood, indicating a long-term effect of
stress on glial cells development (Leventopoulos et al., 2007). It is
reasonable to propose that a deficit in astrocyte’s function plays
a crucial role in the higher susceptibility to PTSD observed in
persons with a previous history of child abuse.
We have previously found a protective effect of intranasal
cotinine administered against RS-induced astrocytes decrease. In
this study, we found that co-treatment of mice with oral cotinine
plus KO prevented the decrease in the number and complexity
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of astrocytes in the DG of mice subjected to RS. In this study, we
observed a beneficial effect of cotinine and cotinine plus KO but
not KO alone in preserving the number and arbor complexity of
astrocytes under conditions of RS.
We have previously shown that, in the absence of stress, long-
term cotinine treatment for up to 8 months did not induce
significant differences in sensory-motor abilities or anxiety in
mice (Zeitlin et al., 2012). Alike these results, no significant
changes in locomotor activity in the mice treated with cotinine,
KO or cotinine plus KO and subjected to RS were found.
Thus, the superior effect of the combination of cotinine plus
KO increasing the escape-oriented behavior in the FS test,
cannot be explained by an increase in locomotor activity induced
by the mix. The open field test is a good test to assess
locomotor activity. However, the interpretation of the time spent
in the center zone as a measure of anxiety has proven to be
misleading and sometimes contradictory (Belzung, 2001a,b; Prut
and Belzung, 2003). For example, it has been shown that many
clinically effective non-benzodiazepine anxiolytics, except 5-
HT1A agonists, these anxiolytic drugs exhibit extremely variable
effects in the open field tests. Alike other anxiolytic drugs
cotinine, KO or cotinine plus KO did not diminish the increased
locomotor activity or time spent in the center zone during the
first 10min of the test, that is considered a measure of anxiety
behavior after prolonged restraint stress.
It is appealing that comparable results were obtained in the
behavioral parameters tested, with a more significant effect of the
mix cotinine plus KO than the individual components in the mix.
The connection between changes in astrocytes and depressive-
like behavior has been reported before. For example, a previous
study reported that the decrease in astrocytes numbers in the
frontal cortex induced by L-alpha-aminoadipic acid provoked
depressive-like behavior in rodents (Lee et al., 2013). This
evidence demonstrated that astroglia ablation in the PFC is
sufficient to prompt depressive-like behaviors comparable to the
one induced by chronic RS. This data strongly suggests that
the loss of astroglia may be a key factor contributing to the
development of long-lasting depression (Lee et al., 2013).
The effect of cotinine in the mix preventing the effect of
stress on mood can be the result of the action of cotinine
as an anti-inflammatory compound inhibiting microgliosis and
neuroinflammation as well as promoting neuronal and astrocyte
survival throughout the activation of pro-survival cell signaling
pathways.
Increased levels of astrocytes may provide neurons with
more energy substrates, glutamate precursors, and neurotrophic
factors. Also, astrocytes can decrease the toxic effect of
the abnormal increase in glutamate release induced by
corticosteroids at the presynaptic level, by uptaking the
glutamate from the synaptic space. On the other hand, KO
components such as omega-3 and astaxanthin can prevent
oxidative stress and diminish the deleterious effects of stress
and Neuroinflammation on brain function (Barros et al., 2014;
Polotow et al., 2015; Figure 7).
A more detailed study of the effect on cotinine and KO on
astrocyte function is guaranteed in the light of the present results.
CONCLUSIONS
In this work, the effect of an oral formulation of cotinine
plus KO to prevent the cognitive and depressive-like behavior
induced by chronic restraint stress. The results show that at
the dose tested, the cotinine plus KO prevented depressive-
like behavior, memory impairment and the astrocytes decrease
induced by RS, and suggests that this formulation may
be useful in humans and non-primates mammals suffering
from restraint stress due to aging or other pathological and
traumatic conditions. Clinical studies are needed to confirm this
hypothesis.
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